Close



Mar 22, 2023 05:05PM
Nov 21, 2022 04:28PM
Nov 21, 2022 04:05PM
Sep 12, 2022 04:05PM
May 12, 2022 04:05PM
Apr 6, 2022 04:06PM
Apr 6, 2022 04:05PM ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology
Apr 4, 2022 01:30AM
Mar 11, 2022 05:18PM
Jan 24, 2022 01:30AM
Jan 3, 2022 04:05PM
Dec 14, 2021 05:45AM
Dec 14, 2021 01:30AM
Dec 13, 2021 04:05PM ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI
Nov 29, 2021 04:07PM
Nov 29, 2021 04:05PM
Nov 15, 2021 04:05PM
Nov 15, 2021 01:30AM
Nov 10, 2021 01:30AM
Oct 25, 2021 05:33AM
Oct 25, 2021 01:00AM ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer
Oct 4, 2021 04:05PM
Sep 20, 2021 04:05PM
Jul 21, 2021 04:05PM
May 4, 2021 04:30PM
Apr 7, 2021 04:30PM
Feb 8, 2021 05:56AM
Feb 8, 2021 01:30AM ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis
Jan 25, 2021 04:30PM
Jan 15, 2021 06:17AM
Jan 14, 2021 04:30PM
Jan 6, 2021 04:30PM
Dec 14, 2020 04:36PM
Dec 14, 2020 04:30PM
Dec 10, 2020 04:30PM ERYTECH to Present at the JMP Securities Hematology Summit
Dec 7, 2020 02:00AM
Dec 3, 2020 04:30PM
Nov 5, 2020 04:30PM
Nov 5, 2020 02:00AM
Nov 2, 2020 03:19AM
Oct 26, 2020 05:30PM
Sep 21, 2020 04:45PM ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
Sep 14, 2020 04:30PM
Jun 9, 2020 06:16AM
Jun 9, 2020 01:30AM
Jun 2, 2020 04:30PM
Jun 1, 2020 01:30AM
May 6, 2020 04:30PM
May 5, 2020 04:30PM ERYTECH engages in collaborative partnership with EU Horizon 2020 EVIDENCE consortium
Apr 28, 2020 06:13PM

976,768 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All